Literature DB >> 35364760

Probing the Interactions Responsible for the Structural Stability of Trypanothione Reductase Through Computer Simulation and Biophysical Characterization.

Anurag Kumar1, Prajakta Nimsarkar1, Shailza Singh2.   

Abstract

With the necessity to develop antileishmanial drugs with substrate specificity, trypanothione reductase (TryR) has gained popularity in parasitology. TryR is unique to be present only in trypanosomatids and is functionally similar to glutathione in mammals. It protects against oxidative stress exerted by the host defense mechanism. The TryR enzyme is essential for the survival of Leishmania parasites in the host as it reduces trypanothione and aids in neutralizing hydrogen peroxide produced by the host macrophages during infection. Henceforth, it becomes vital to decipher their functional stability and behaviour in the presence of denaturants. Our study is focused on structural, functional and behavioural stability aspects of TryR with different concentrations of Urea, Guanidinium chloride, alcohol based compounds followed by extensive molecular dynamics simulations in a lipid bilayer system. The results obtained from the study reveal an interesting insight into the possible mechanisms of modulation of the structure, function and stability of the TryR protein.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Dipalmitoylphosphatidylcholine (DPPC); Functional stability; Guanidinium chloride; Molecular dynamics simulation; Protein folding; Trypanothione reductase; Urea

Mesh:

Substances:

Year:  2022        PMID: 35364760     DOI: 10.1007/s10930-022-10052-x

Source DB:  PubMed          Journal:  Protein J        ISSN: 1572-3887            Impact factor:   2.371


  36 in total

Review 1.  Free radicals and phagocytic cells.

Authors:  G M Rosen; S Pou; C L Ramos; M S Cohen; B E Britigan
Journal:  FASEB J       Date:  1995-02       Impact factor: 5.191

Review 2.  Identifying vaccine targets for anti-leishmanial vaccine development.

Authors:  Shyam Sundar; Bhawana Singh
Journal:  Expert Rev Vaccines       Date:  2014-04       Impact factor: 5.217

3.  Pseudoirreversible slow-binding inhibition of trypanothione reductase by a protein-protein interaction disruptor.

Authors:  Héctor de Lucio; Miguel A Toro; María-José Camarasa; Sonsoles Velázquez; Federico Gago; Antonio Jiménez-Ruiz
Journal:  Br J Pharmacol       Date:  2020-10-02       Impact factor: 8.739

Review 4.  Leishmaniasis.

Authors:  David Pace
Journal:  J Infect       Date:  2014-09-17       Impact factor: 6.072

5.  The oxidative response of rabbit peritoneal neutrophils to leishmanias and other trypanosomatids.

Authors:  D J Mallinson; J M Lackie; G H Coombs
Journal:  Int J Parasitol       Date:  1989-09       Impact factor: 3.981

Review 6.  Survival Mechanisms Used by Some Leishmania Species to Escape Neutrophil Killing.

Authors:  Ivo B Regli; Katiuska Passelli; Benjamin P Hurrell; Fabienne Tacchini-Cottier
Journal:  Front Immunol       Date:  2017-11-16       Impact factor: 7.561

Review 7.  The evolution of trypanosomatid taxonomy.

Authors:  Alexa Kaufer; John Ellis; Damien Stark; Joel Barratt
Journal:  Parasit Vectors       Date:  2017-06-08       Impact factor: 3.876

8.  Identification and binding mode of a novel Leishmania Trypanothione reductase inhibitor from high throughput screening.

Authors:  Lorenzo Turcano; Esther Torrente; Antonino Missineo; Matteo Andreini; Marina Gramiccia; Trentina Di Muccio; Ilaria Genovese; Annarita Fiorillo; Steven Harper; Alberto Bresciani; Gianni Colotti; Andrea Ilari
Journal:  PLoS Negl Trop Dis       Date:  2018-11-26

9.  Understanding the Cross-Talk of Redox Metabolism and Fe-S Cluster Biogenesis in Leishmania Through Systems Biology Approach.

Authors:  Anurag Kumar; Nutan Chauhan; Shailza Singh
Journal:  Front Cell Infect Microbiol       Date:  2019-02-04       Impact factor: 5.293

Review 10.  Drug resistance and treatment failure in leishmaniasis: A 21st century challenge.

Authors:  Alicia Ponte-Sucre; Francisco Gamarro; Jean-Claude Dujardin; Michael P Barrett; Rogelio López-Vélez; Raquel García-Hernández; Andrew W Pountain; Roy Mwenechanya; Barbara Papadopoulou
Journal:  PLoS Negl Trop Dis       Date:  2017-12-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.